Leukodystrophy, Metachromatic: Clinical Trials

3 trials for Leukodystrophy, Metachromatic, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 terminated. 3 Phase 2, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 23Terminated 3
Phase 11Terminated 1

Follow Leukodystrophy, Metachromatic: new trials by email Literature Review of Leukodystrophy, Metachromatic trials Research Report on Leukodystrophy, Metachromatic

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Phase I/II Pilot Study of Mixed Chimerism to Treat Inherited Metabolic Disorders
hematopoietic stem cell infusion - Hurler Syndrome (MPS I), Hurler-Scheie Syndrome
Phase 1 / Phase 2TerminatedTalaris Therapeutics Inc.32011-04-012023-04-12
Hematopoietic Stem Cell Transplantation (HCT) for Inborn Errors of Metabolism
Stem Cell Transplantation, Cyclophosphamide, Campath-1H - Hurler's Syndrome, Maroteaux-Lamy Syndrome
Phase 2TerminatedMasonic Cancer Center, University of Minnesota182008-03-012017-12-28
Open-Label Extension Study of Recombinant Human Arylsulfatase A (HGT-1111) in Late Infantile MLD
HGT-1111 - Late Infantile Metachromatic Leukodystrophy
Phase 2TerminatedShire112008-02-202021-06-08

Narrower conditions

Leukodystrophy, Globoid Cell (2)  ·  Mucopolysaccharidosis I (2)  ·  alpha-Mannosidosis (2)  ·  Adrenoleukodystrophy (1)  ·  Aspartylglucosaminuria (1)  ·  Fucosidosis (1)  ·  Metabolism, Inborn Errors (1)  ·  Mucopolysaccharidosis II (1)  ·  Mucopolysaccharidosis III (1)  ·  Mucopolysaccharidosis VI (1)  ·  Mucopolysaccharidosis VII (1)  ·  Niemann-Pick Disease, Type B (1)  ·  Niemann-Pick Disease, Type C (1)  ·  Niemann-Pick Diseases (1)

Broader conditions

Brain Diseases (3)  ·  Brain Diseases, Metabolic (3)  ·  Brain Diseases, Metabolic, Inborn (3)  ·  Central Nervous System Diseases (3)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (3)  ·  Demyelinating Diseases (3)  ·  Genetic Diseases, Inborn (3)  ·  Hereditary Central Nervous System Demyelinating Diseases (3)  ·  Leukoencephalopathies (3)  ·  Lipid Metabolism Disorders (3)  ·  Lipid Metabolism, Inborn Errors (3)  ·  Lipidoses (3)  ·  Lysosomal Storage Diseases (3)  ·  Lysosomal Storage Diseases, Nervous System (3)  ·  Metabolic Diseases (3)

Interventions

Stem Cell Transplantation (2)  ·  Alemtuzumab (1)  ·  Bone Marrow Transplantation (1)  ·  Busulfan (1)  ·  Cyclophosphamide (1)

Sponsors

Masonic Cancer Center, University of Minnesota (1)  ·  Shire (1)  ·  Talaris Therapeutics Inc. (1)

Countries

United States (2)  ·  Denmark (1)

Top investigators

Paul Orchard, MD (1)  ·  Suzanne T Ildstad, MD (1)

Results publications

PMID 21586746, PMID 33332761

NIH funding

2008 (1)